Functional validation of genes implicated in lymphomagenesis: an in vivo selection assay using a Myc-induced B-cell tumor.
about
Widespread microRNA repression by Myc contributes to tumorigenesisp53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitorsMeta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications.The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centersCross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models.Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features.Vitamin C restores healthy aging in a mouse model for Werner syndromePIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancerNFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network.18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancersMYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.Microenvironment abnormalities and lymphomagenesis: Immunological aspects.B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancerTumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages.c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster.MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.Niche-independent high-purity cultures of Lgr5+ intestinal stem cells and their progeny.Gene signatures in hepatocellular carcinoma (HCC).PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1.Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs.Early and late effects of pharmacological ALK inhibition on the neuroblastoma transcriptome.
P2860
Q24647067-70F55CF3-3787-468E-B89C-3250DCBF635FQ28757630-6ADFBD7E-4B5A-4CB9-83BE-477F2D67E6D7Q33416006-8BD1AF99-5A77-4157-BCE3-DF388BC6C465Q33702365-85F4558F-B32E-4AD6-9C35-CECFA711D492Q34044132-D2E4B480-084D-42CB-A418-0C87950594DBQ34310234-A3130109-C2F7-4BDC-AF8E-E6B8D4387FB2Q34866372-2B101E3D-A56C-4C9C-B577-B8D37D57C9A2Q35001920-3E78FCEA-DE08-4E99-960B-384353372B2EQ35078578-E273F690-D488-4F32-A409-14EB128DC62AQ35102233-B0D9D9D4-F705-4177-80D4-540D9916C9B5Q35141499-1F4E443F-681B-42C0-99DB-475A71FF84F6Q35741642-97EDA365-DFFE-48A2-9054-7137868FE146Q36118020-DE1A6259-E53A-40C9-B72B-ACFF2786882AQ36243554-43071260-A4E2-4D4E-87F4-1EAB3F6C0A52Q37207049-63B4CA9F-6C0E-41DC-A134-5FF2E96B5CD1Q37335244-616EC919-E254-48E8-BA07-51A573D8960CQ37439625-D132A222-D673-4FD1-A6AC-2FF3BD4DDA59Q37617063-0CCEF30B-64F2-4845-9101-ED77B8D8DAD0Q37633867-47F1C2EA-40D6-4AD5-B75B-F94F1D04AED5Q37790070-18CC2E85-71B7-48BE-B904-79A8952DF705Q38735131-19A930CE-BE66-4194-81B7-42704ABCD542Q41816083-ADB304EE-FD63-4E13-96B7-EBBDBE5319B4Q42272234-164ABE9D-3894-45E2-999C-5C63235C114DQ42694831-FB97D074-D2DF-4BE3-A845-0EC56D5CBF7DQ43084886-8F79921A-481A-4C97-8949-78E2B68B381EQ45012890-FD39FCAC-3F37-47CE-A7CD-1C6877BCF523Q47102779-06FEE165-13EA-4682-8FA6-24590984E57D
P2860
Functional validation of genes implicated in lymphomagenesis: an in vivo selection assay using a Myc-induced B-cell tumor.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@ast
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@en
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@nl
type
label
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@ast
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@en
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@nl
prefLabel
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@ast
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@en
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@nl
P2093
P2860
P356
P1476
Functional validation of genes ...... ng a Myc-induced B-cell tumor.
@en
P2093
Andrea Park
Andrei Thomas-Tikhonenko
Diana Cozma
P2860
P304
P356
10.1196/ANNALS.1339.047
P407
P577
2005-11-01T00:00:00Z